SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
滴滴滴
Lv4
7
450 积分
2023-11-03 加入
最近求助
最近应助
互助留言
Phase II Study of Sintilimab Combined with Concurrent Chemoradiotherapy in Patients with Limited-Stage Small Cell Lung Cancer (SINCE-01 Trial)
1小时前
已完结
154TiP AdvanTIG-204: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus anti-PD-1 mAb tislelizumab (TIS) plus concurrent chemoradiotherapy (cCRT) in patients (pts) with untreated limited-stage small cell lung cancer (LS-SCLC)
1小时前
已完结
CDK7 as a biomarker to predict response to etoposide and carboplatin treatment in limited-stage small cell lung cancer with surgical resection
1天前
已完结
198P Adebrelimab with concurrent chemoradiation (cCRT) for limited-stage small cell lung cancer (LS-SCLC): Safety run-in results of a phase III trial
4天前
已完结
Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer
8天前
已完结
Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer
8天前
已完结
The Research Progress of Immune Checkpoint Inhibitor and Chemoradiotherapy for Limited Stage Small Cell Lung Cancer
10天前
已完结
Abstract CT067: Pembrolizumab with and without sacituzumab govitecan as first-line treatment for metastatic non-small-cell lung cancer (NSCLC) with PD-L1 TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study
11天前
已关闭
The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers
13天前
已完结
What Are the Biomarkers for Immunotherapy in SCLC?
13天前
已完结
没有进行任何应助
不是这个研究的附件哦
5个月前
已找到【积分已退回】
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论